A. Debnath

发表

Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.

A. Debnath, R. L. Lopez de Compadre, G. Debnath, 1991, Journal of medicinal chemistry.

Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles

A. Debnath, Shibo Jiang, A. Neurath, 2002, BMC infectious diseases.

Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops

Young Do Kwon, Tongqing Zhou, Peter D. Kwong, 2012, Proceedings of the National Academy of Sciences.

Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase.

Asim Kumar Debnath, A. Debnath, 2002, Journal of medicinal chemistry.

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

A. Debnath, A. Neurath, N. Strick, 2001, BMC infectious diseases.

Design of a Protein Surface Antagonist Based on α-Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion We thank the National Institutes of Health for support of this work and the Deutsche Forschungsgemeinschaft (DFG) for a research fellowship to O.K.

A. Debnath, A. Hamilton, Hong Lu, 2002 .

Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain

A. Debnath, D. Cowburn, E. Freed, 2011, Retrovirology.

Novel structures of self-associating stapled peptides.

A. Debnath, D. Cowburn, S. Bhattacharya, 2012, Biopolymers.

Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.

A. Debnath, A. Altieri, F. Curreli, 2021, Bioorganic & medicinal chemistry.

Low temperature processable ultra-thin WO3 Langmuir-Blodgett film as excellent hole blocking layer for enhanced performance in dye sensitized solar cell

Tanvi, D. K. Aswal, A. Debnath, 2019, Electrochimica Acta.

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

A. Debnath, P. Tien, Gengfu Xiao, 2004, The Lancet.

The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 gp41 Is Critical for Viral Fusion and Entry

A. Debnath, Lu Lu, Shibo Jiang, 2012, PloS one.

Conserved Residue Lys574 in the Cavity of HIV-1 Gp41 Coiled-coil Domain Is Critical for Six-helix Bundle Stability and Virus Entry*

A. Debnath, F. Kirchhoff, Hong Lu, 2007, Journal of Biological Chemistry.

Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.

A. Debnath, Soohee Lee, C. Redman, 2003, Blood.

Electrocatalytic Production of Hydrogen‐peroxide from Molecular Oxygen by Rare Earth (Pr, Nd, Sm or Gd) Oxide Nanorods

A. Debnath, A. Debnath, K. Muthe, 2020 .

Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.

A. Debnath, D. Cowburn, X. An, 2008, Biochimica et biophysica acta.

Mutagenic activity of a series of synthetic and naturally occurring heterocyclic amines in Salmonella.

A. Debnath, C. Hansch, T. Lawlor, 1992, Mutation research.

The importance of hydrophobicity in the mutagenicity of methanesulfonic acid esters with Salmonella typhimurium TA100.

A. Debnath, C. Hansch, 1993, Chemical research in toxicology.

Synthesis, Antiviral Activity, and Structure–Activity Relationship of 1,3‐Benzodioxolyl Pyrrole‐Based Entry Inhibitors Targeting the Phe43 Cavity in HIV‐1 gp120

A. Debnath, A. Altieri, F. Curreli, 2018, ChemMedChem.

Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.

A. Debnath, A. Altieri, F. Curreli, 2016, Bioorganic & medicinal chemistry.

Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

A. Debnath, F. Curreli, Jinfeng Xu, 2015, Bioorganic & medicinal chemistry.

Design of antiviral stapled peptides containing a biphenyl cross-linker.

A. Debnath, Nan Li, Qing Lin, 2014, Bioorganic & medicinal chemistry letters.

Characterization and device application of indium doped ZnO homojunction prepared by RF magnetron sputtering

S. C. Gadkari, A. Debnath, A. Debnath, 2020 .

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4

A. Debnath, Lu Lu, Shibo Jiang, 2013, Journal of Infection.

A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity

A. Debnath, L. Du, Wanbo Tai, 2022, BMC biology.

Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors

A. Debnath, Shibo Jiang, L. Du, 2019, Viruses.

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

A. Debnath, Lu Lu, Shibo Jiang, 2013, Journal of Virology.

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC

A. Debnath, Lu Lu, Shibo Jiang, 2012, Journal of Infection.

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

A. Debnath, Lu Lu, Shibo Jiang, 2013, Journal of Virology.

ADS-J 1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp 41 Pocket Region and Blocking Fusion-Active gp 41 Core Formation

A. Debnath, Hong Lu, X. An, 2009 .

Conserved Salt-bridge between the Nand C-Terminal Heptad Repeat Regions of HIV-1 gp 41 Core Structure Is Critical for Virus Entry and Inhibition

A. Debnath, Shibo Jiang, Shuwen Liu, 2008 .

Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

A. Debnath, Hong Lu, Shibo Jiang, 2005, Biochimica et biophysica acta.

HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites.

A. Debnath, E. Arnold, K. Das, 2021, Journal of Medicinal Chemistry.

Guanidine‐Containing Phenyl‐Pyrrole Compounds as Probes for Generating HIV Entry Inhibitors Targeted to gp120

A. Debnath, A. Altieri, F. Curreli, 2018, ChemistrySelect.

Synthesis of 5-Arylpyrrole-2-carboxylic Acids as Key Intermediates for NBD Series HIV-1 Entry Inhibitors

A. Debnath, A. Altieri, F. Curreli, 2017 .

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

A. Debnath, Lu Lu, Shibo Jiang, 2015, Current topics in medicinal chemistry.

α-Helix-Mimetic Foldamers for Targeting HIV-1 TAR RNA.

A. Debnath, A. Hamilton, Sunil Kumar, 2019, Chemistry.

Anomalous Sensing Response of NiO Nanoparticulate Films toward H2S

S. C. Gadkari, A. Debnath, Ranjit Singh, 2019, ACS Applied Nano Materials.

Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitors.

A. Debnath, A. Katritzky, Hong Lu, 2009, Journal of medicinal chemistry.

Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs

A. Debnath, Shibo Jiang, Keliang Liu, 2008, Biochemical and Biophysical Research Communications.

3-Hydroxyphthaloyl-β-Lactoglobulin. I. Optimization of Production and Comparison with other Compounds Considered for Chemoprophylaxis of Mucosally Transmitted Human Immunodeficiency Virus Type 1

A. Debnath, Shibo Jiang, A. Neurath, 1997 .

3-Hydroxyphthaloyl-β-Lactoglobulin. II. Anti-Human Immunodeficiency Virus Type 1 Activity in in Vitro Environments Relevant to Prevention of Sexual Transmission of the Virus

A. Debnath, Shibo Jiang, A. Neurath, 1997 .

Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.

A. Debnath, A. Katritzky, Hong Lu, 2011, Bioorganic & medicinal chemistry letters.

Elucidation of structural, morphological, optical and photoluminescence properties of single and (In, Ga) co-doped ZnO nanocrystalline thin films

S. C. Gadkari, A. Debnath, K. G. Girija, 2019, Bulletin of Materials Science.

Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors that Potently Reactivate Latent HIV

A. Debnath, F. Curreli, Shahad Ahmed, 2020, Viruses.

Ag ion implanted TiO2 photoanodes for fabrication of highly efficient and economical plasmonic dye sensitized solar cells

D. K. Aswal, A. Debnath, D. Aswal, 2020 .

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists

A. Debnath, P. Kwong, Y. Kwon, 2022, International journal of molecular sciences.

Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41.

A. Debnath, A. Katritzky, Hong Lu, 2011, Journal of medicinal chemistry.

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model

A. Debnath, S. Horrigan, C. Stoddart, 2022, Viruses.

Tin Protoporphyrin IX Used in Control of Heme Metabolism in Humans Effectively Inhibits HIV-1 Infection

A. Debnath, Shibo Jiang, A. Neurath, 1994 .

Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.

A. Debnath, C. Hansch, Y. Martin, 1993, Journal of medicinal chemistry.

N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion

A. Debnath, Hong Lu, Shibo Jiang, 2004, Antimicrobial Agents and Chemotherapy.

Synthesis of 2-Oxo-1, 2-Dihydroquinoline Chemotype with Multiple Attachment Points as Novel Screening Compounds for Drug Discovery.

A. Debnath, A. Altieri, I. Andreev, 2016, JSM Chemistry.

Mutagenicity of quinolines in Salmonella typhimurium TA100. A QSAR study based on hydrophobicity and molecular orbital determinants.

A. Debnath, C. Hansch, A K Debnath, 1992, Mutation research.

Targeting HIV‐TB coinfection by developing novel piperidin‐4‐substituted imines: Design, synthesis, in vitro and in silico studies

A. Debnath, D. Sriram, K. Pai, 2019, Archiv der Pharmazie.

ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation

A. Debnath, Hong Lu, X. An, 2009, Antimicrobial Agents and Chemotherapy.

Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate.

A. Debnath, U. Desai, D. Shukla, 2007, Biomacromolecules.

Tailoring of the chlorine sensing properties of substituted metal phthalocyanines non-covalently anchored on single-walled carbon nanotubes

D. K. Aswal, A. Debnath, A. Mahajan, 2018, RSC advances.

Comparative Quantitative Structure−Activity Relationship Studies on Anti-HIV Drugs

C. Hansch, A. Debnath, Hua Gao, 1999 .

Dual-acting stapled peptides target both HIV-1 entry and assembly

A. Debnath, M. Summers, E. Freed, 2013, Retrovirology.

A cell-penetrating helical peptide as a potential HIV-1 inhibitor.

A. Debnath, D. Cowburn, E. Freed, 2008, Journal of molecular biology.

Characterization of a Novel Filarial Serine Protease Inhibitor, Ov-SPI-1, from Onchocerca volvulus, with Potential Multifunctional Roles during Development of the Parasite*

A. Debnath, M. Blaxter, D. Guiliano, 2005, Journal of Biological Chemistry.

Solution Structure of a Hydrocarbon Stapled Peptide Inhibitor in Complex with Monomeric C-terminal Domain of HIV-1 Capsid*

A. Debnath, D. Cowburn, S. Bhattacharya, 2008, Journal of Biological Chemistry.

A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimurium TA98 and TA100

A. Debnath, G. Debnath, A. Shusterman, 1992, Environmental and molecular mutagenesis.

Molecular basis of two novel high‐prevalence antigens in the Kell blood group system, KALT and KTIM

A. Debnath, C. Lomas‐Francis, M. Reid, 2006, Transfusion.

Punica granatum (Pomegranate) Juice Provides an HIV‐1 Entry Inhibitor and Candidate Topical Microbicide

A. Debnath, A. Neurath, N. Strick, 2005, Annals of the New York Academy of Sciences.

Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide

A. Debnath, A. Neurath, N. Strick, 2004, BMC infectious diseases.

Expansion of the Kell blood group system: two new high‐prevalence antigens and two novel K0 (Kellnull) phenotypes

A. Debnath, M. Uchikawa, C. Westhoff, 2013, Transfusion.

Molecular basis of two novel and related high‐prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI

A. Debnath, W. Flegel, T. Peyrard, 2013, Transfusion.

Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

A. Debnath, S. Heck, K. Yazdanbakhsh, 2007, Biochemical and biophysical research communications.

Preclinical optimization of gp120 entry-antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation.

A. Debnath, A. Altieri, F. Curreli, 2020, Journal of medicinal chemistry.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Asim Kumar Debnath, Shibo Jiang, Nouri Neamati, 2005, Virology.

XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41.

A. Debnath, A. Hamilton, Shibo Jiang, 2002, AIDS research and human retroviruses.

Rational design of HIV-1 entry inhibitors.

Asim K Debnath, A. Debnath, 2013, Methods in molecular biology.

Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

A. Debnath, P. Kwong, Y. Kwon, 2017, Journal of medicinal chemistry.

Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

Young Do Kwon, Asim K Debnath, Peter D Kwong, 2017, Journal of medicinal chemistry.

Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.

Young Do Kwon, Hongtao Zhang, Asim K Debnath, 2015, Journal of medicinal chemistry.

Bovine β–lactoglobulin modified by 3–hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV

Shibo Jiang, A. Debnath, Shibo Jiang, 1996, Nature Medicine.

Application of 3D-QSAR techniques in anti-HIV-1 drug design--an overview.

Asim Kumar Debnath, A. Debnath, 2005, Current pharmaceutical design.

Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion.

Shibo Jiang, Asim K Debnath, A. Debnath, 2002, Angewandte Chemie.

Antiviral Activity of Dual-acting Hydrocarbon-stapled Peptides against HIV-1 Predominantly Circulating in China.

A. Debnath, K. Hong, Shibo Jiang, 2017, Biomedical and environmental sciences : BES.

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors

A. Debnath, C. Hillyer, F. Curreli, 2023, bioRxiv.

Comparative Molecular Field Analysis (CoMFA) of a Series of Symmetrical Bis-Benzamide Cyclic Urea Derivatives as HIV-1 Protease Inhibitors

Asim Kumar Debnath, A. Debnath, 1998, J. Chem. Inf. Comput. Sci..

Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1

A. Debnath, 2006, Expert opinion on investigational drugs.

Quantitative structure‐activity relationship investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella typhimurium TA100

A. Debnath, A. Shusterman, C. Hansch, 1992, Environmental and molecular mutagenesis.

Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition

A. Debnath, Hong Lu, Shibo Jiang, 2008, Journal of Virology.

Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV‐1) envelope glycoprotein gp120

A. Debnath, A. Neurath, N. Strick, 1995, Journal of molecular recognition : JMR.

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1.

A. Debnath, Shibo Jiang, S. Jiang, 1999, Journal of medicinal chemistry.

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro

A. Debnath, C. Hillyer, C. Tseng, 2020, bioRxiv.

Design, synthesis, and antiviral activity of entry inhibitors that target the CD4-binding site of HIV-1.

A. Debnath, P. Kwong, Y. Kwon, 2012, Journal of medicinal chemistry.

Peptide and non-peptide HIV fusion inhibitors.

A. Debnath, Shibo Jiang, Qian Zhao, 2002, Current pharmaceutical design.

Dual-acting stapled peptides target both HIV-1 entry and assembly

A. Debnath, M. Summers, E. Freed, 2013, Retrovirology.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

A. Debnath, S. Jiang, A. Neurath, 1994, Journal of medicinal chemistry.

Titanium Hydride targets for Portable Neutron Generator applications

A. Debnath, R. Jat, Y. Kashyap, 2021 .

Solution processable transition metal oxide ultra-thin films as alternative electron transport and hole blocking layers in dye sensitized solar cells

R. K. Bedi, A. Debnath, O. Prakash, 2021 .

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket

Lu Lu, Shibo Jiang, Fei Yu, 2013, Viruses.

A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5.

A. Debnath, Yuxian He, G. Alespeiti, 2004, Virology.

Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.

A. Debnath, J. Hoxie, J. Mascola, 2011, ACS chemical biology.

Quantitative structure-activity relationship (QSAR) paradigm--Hansch era to new millennium.

A. Debnath, A K Debnath, 2001, Mini reviews in medicinal chemistry.

Investigation on gas sensing properties of Ag doped BiFeO3

A. Debnath, V. Shelke, S. Bhattacharya, 2018 .

Fabrication of plasmonic dye-sensitized solar cells using ion-implanted photoanodes

A. Debnath, D. Aswal, V. Saxena, 2019, RSC advances.

Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)

A. Debnath, C. Hillyer, C. Tseng, 2021, bioRxiv.

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays

A. Debnath, C. Hillyer, C. Tseng, 2021, Viruses.

Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.

Asim Kumar Debnath, A. Debnath, 2003, Journal of medicinal chemistry.

Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.

A. Debnath, L. Iyer, Y. Kwon, 2018, European journal of medicinal chemistry.

Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study

A. Debnath, P. Kwong, Yongping Yang, 2014, Antimicrobial Agents and Chemotherapy.

International Commission for Protection Against Environmental Mutagens and Carcinogens. The importance of the hydrophobic interaction in the mutagenicity of organic compounds.

A. Debnath, R. L. Lopez de Compadre, A. Shusterman, 1994, Mutation research.

Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects.

A. Debnath, A. Shusterman, C. Hansch, 1989, Molecular pharmacology.

Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid.

Hongtao Zhang, Ilya Pyatkin, Asim K Debnath, 2011, Bioorganic & medicinal chemistry.

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV‐1) by chemically modified bovine milk proteins: Potential for AIDS prophylaxis

A. Debnath, Shibo Jiang, A. Neurath, 1995, Journal of molecular recognition : JMR.

structure‐activity relationship of genotoxic polycyclic aromatic nitro compounds: Further evidence for the importance of hydrophobicity and molecular orbital energies in genetic toxicity

A. Debnath, C. Hansch, A K Debnath, 1992, Environmental and molecular mutagenesis.

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

A. Debnath, N. Strick, Yun-yao Li, 2001, BMC infectious diseases.

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

A. Debnath, A. K. Debnath, S. Jiang, 2000, Biochemical and biophysical research communications.

LUMO Energies and hydrophobicity as determinants of mutagenicity by nitroaromatic compounds in Salmonella typhimurium

A. Debnath, R. L. Lopez de Compadre, A. Shusterman, 1990, Environmental and molecular mutagenesis.

Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site

A. Debnath, Judith M. LaLonde, P. Kwong, 2014, PloS one.

Synergistic effect of indium and gallium co-doping on the properties of RF sputtered ZnO thin films

A. Debnath, K. G. Girija, M. Kaur, 2018 .

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

A. Debnath, S. Jiang, K. Lin, 1999, Journal of virological methods.

ectodomain based on the structure of neutral endopeptidase 24.11 Active amino acids of the Kell blood group protein and model of the

A. Debnath, Soohee Lee, C. Redman, 2013 .

Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.

A. Debnath, A K Debnath, 1999, Journal of medicinal chemistry.

Synthesis and anti-HIV-1 activity of 4-[4-(4,6-bisphenylamino-[1,3,5]triazin-2-ylamino)-5-methoxy-2-methylphenylazo]- 5-hydroxynaphthalene-2,7-disulfonic acid and its derivatives

A. Debnath, Lai-Xi Wang, Hong Lu, 2004 .